SH2D1A Antikörper (AA 85-114)
-
- Target Alle SH2D1A Antikörper anzeigen
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
-
Bindungsspezifität
- AA 85-114
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SH2D1A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Spezifität
- This SH2D1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 85-114 amino acids from the C-terminal region of human SH2D1A.
- Aufreinigung
- Affinity purified
- Isotyp
- IgG
- Top Product
- Discover our top product SH2D1A Primärantikörper
-
-
- Applikationshinweise
- Approved: ELISA (1:1000), WB (1:100 - 1:500)
- Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
- Target
- SH2D1A (SH2 Domain Containing 1A (SH2D1A))
- Andere Bezeichnung
- SH2D1A / SAP (SH2D1A Produkte)
- Synonyme
- DSHP antikoerper, EBVS antikoerper, IMD5 antikoerper, LYP antikoerper, MTCP1 antikoerper, SAP antikoerper, SAP/SH2D1A antikoerper, XLP antikoerper, XLPD antikoerper, RGD1562408 antikoerper, Gm686 antikoerper, SH2D1A antikoerper, SH2 domain containing 1A antikoerper, SH2D1A antikoerper, Sh2d1a antikoerper
- Hintergrund
-
Name/Gene ID: SH2D1A
Synonyms: SH2D1A, LYP, IMD5, SH2 domain protein 1A, SH2 domain containing 1A, XLP, XLPD, DSHP, Duncan disease SH2-protein, EBVS, Lymphoproliferative syndrome, SAP, SLAM-associated protein - Gen-ID
- 4068
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-